Anthelios Sx, Capital Soleil 15 (ecamsule) is a small molecule pharmaceutical. Ecamsule was first approved as Anthelios Sx on 2006-07-21.
Trade Name |
Anthelios Sx, Capital Soleil 15 |
Common Name |
Ecamsule |
Indication |
|
Drug Class |
Camphorsulfonic acid derivatives used as UVA sunscreens |